IVGIX Fees and Costs — Vy(r) Invesco Growth and Income Portfolio, Class I
Data updated: 2026-08-21
The net expense ratio is 0.65%: a 0.64% management fee plus 0.01% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $36K in broker commissions, 0.0233% of average net assets, and portfolio turnover was 27%.
IVGIX Fees and Expenses
Annual operating expenses and sales charges of IVGIX. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.64% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.01% |
| Gross expense ratio | 0.65% |
| Fee waiver | — |
| Net expense ratio | 0.65% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
IVGIX Costs Over Time
On $10,000 invested in IVGIX, assuming 5% a year before costs, total costs come to $424 over 5 years, cutting the return by 0.71% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.65%) | $68 | $214 | $372 |
| Trading costs (broker commissions) | $2 | $8 | $13 |
| Lost growth on money paid in costs | $0 | $11 | $39 |
| Total costs | $71 | $232 | $424 |
| Value after costs | $10,429 | $11,344 | $12,339 |
| Impact on return, per year | 0.71% | 0.71% | 0.71% |
IVGIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0233%
- Total broker commissions: $36K
- Bought from dealers (principal trades, not a cost): $38.3M
- Portfolio turnover (prospectus): 27%
- Securities on loan, average value: $124K
- Net income from securities lending: $1K (0.001% of average net assets)
IVGIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BOFA SECURITIES, INC. | $5K | 15.65% |
| UBS Securities LLC | $4K | 15.18% |
| INTERCOASTAL CAPITAL MARKETS, INC | $4K | 13.38% |
| GOLDMAN SACHS & CO. LLC | $4K | 12.87% |
| MORGAN STANLEY & CO. LLC | $4K | 11.96% |
| CITIGROUP GLOBAL MARKETS INC. | $3K | 9.79% |
| J.P. Morgan Securities LLC | $2K | 7.70% |
| JEFFERIES LLC | $2K | 5.16% |
| WELLS FARGO SECURITIES, LLC | $1K | 4.17% |
| RBC CAPITAL MARKETS, LLC | $1K | 4.13% |
IVGIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| THE BANK OF NEW YORK MELLON | $38.2M | 99.58% |
| NATIONAL FINANCIAL SERVICES LLC | $160K | 0.42% |
Vy(r) Invesco Growth and Income Portfolio Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| IVGIX | Class I | 0.65% | — |
| IVGSX | Class S | 0.90% | — |
| IVITX | Class S2 | 1.05% | — |
| IVGAX | Class ADV | 1.25% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.